U.S. stocks move: 10x Genomics surged on October 9th due to target price upgrade, Fred Hutchinson collaboration, and spatial genomics.
Bitget异动解读2026/10/09 14:0510x Genomics October 9th Surge Analysis
Keywords: Target Price Raise, Fred Collaboration, Spatial Omics
1. On October 9th, BofA Securities raised the target price for 10x Genomics from $50 to $80 and maintained a hold rating.
2. On October 7th, the company reached a multi-project research collaboration with Fred Hutchinson Cancer Center, utilizing the Flex Apex, Xenium, and upcoming Atera platforms to conduct biomarker discovery in bladder cancer and minimal residual disease detection in acute myeloid leukemia, driving the application of single-cell and spatial technologies into clinical research of solid tumors and hematologic malignancies.
(Disclaimer: This content is generated by AI technology based on public information summary, for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. stocks move | Moderna (MRNA.US) rises 7% after being included in the Nasdaq 100 Index
According to information from Zhihui Finance APP, on Friday, Moderna (MRNA.US) surged as much as 10% during trading, reaching its highest share price since December 2022. As of press time, the gain narrowed to 7%, with the stock trading at $210.95. On the news front, on October 9, Moderna was officially included in the Nasdaq 100 index, replacing Warner Bros Discovery. After its inclusion, some broad-based institutions that previously did not allocate to biotech will now passively hold the stock, while active institutions will add the company to their watch lists, increasing attention on the individual stock.
FCC Chairman Carr expresses satisfaction with the progress of the Disney lawsuit
FCC Chairman Carr stated that he is "satisfied" with the progress of the lawsuit against Disney (DIS.US).
